|
Free
Zepbound's 80% revenue jump signals upside, but access and supply cap the bull case.
|
Free
Examining layoffs, Game Pass missteps, regulatory threats, and the $627B commercial backlog.
|
Free
Structural peptide demand favors Lilly, but peer data falls short of valuation proof.
|
Free
Cloud gross margins slide to 66% while capital expenditure reaches 30% of revenue in a capital-intensive transformation.
|
Free
An exhaustive analysis of Xbox layoffs, AI commoditization, and the strategic risks Microsoft faces in its pursuit of dominance.
|
Free
Strong beat and raised guidance meet rich multiples and heavy reinvestment cash drag.
|
Free
Oral GLP-1 and global filings signal a platform shift beyond injectable franchises.
|
Free
As Microsoft sends Halo to PlayStation, the traditional console war model gives way to ecosystem monetization.
|
Free
Higher prices and exclusivity shift could boost margins, but subscriber churn and competitive threats remain risks.